War on Disease
War on Disease
Invite
Back to Treatments
Treatment
Transcatheter Aortic Valve Replacement (TAVR)
1
Conditions
550
Trials
120K
Participants
45%
Average Safety
Condition Evidence
Non-rheumatic calcific aortic valve disease
550 trials Β· 120K participants
90% effectiveness Β· 45% safety
Transcatheter Aortic Valve Replacement (TAVR) | DFDA